Custom Search
Clorazepate News
Clorazepate dipotassium versus midazolam for premedication in clear corneal cataract surgery
To evaluate and compare the efficacy of oral clorazepate dipotassium (Tranxilium®) and intravenous midazolam (Dormicum®) as premedication agents in retrobulbar anesthesia and clear corneal phacoemulsification with intraocular...
Company to Pay Penalty In Price-Fixing Suit
Mylan Laboratories, a maker of antianxiety and other drugs, agreed to a tentative settlement of an antitrust lawsuit last month. The FTC alleged that Mylan conspired to monopolize the generic market for lorazepam and clorazepate...
New York joins $100 million nationwide monopoly settlement in principle with anxiety drug maker
State Attorney General Eliot Spitzer today announced that New York, 32 other states and the Federal Trade Commission ("F.T.C.") have reached a settlement in principle with Mylan Laboratories, in the amount of $100 million, for...
Displaying results 6 to 8 out of 8